CompoAtlas

Crystaderm®

Natural health product licensed in Canada

Licence holder
Combomed Pharmaceutical Inc.
NPN or DIN-HM
80128021
Status
Active licence
Licence date
14 November 2023
Revision date
22 January 2026
Form
Crème
Route of administration
Topique
Application type
Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Peroxyde d'hydrogène

Source : Peroxyde d'hydrogène

1 % (p/p)

Non-medicinal ingredients

Stéarate de PEG-100, Acide sulfurique, Édétate disodique, Acide salicylique, Hydroxyde de sodium, Acide citrique, Pyrophosphate de disodium, Stannate de sodium (IV), Eau purifiée, Laurate de glycérol, Oxalate de sodium, Myristate de glycéryle, Propylène glycol

PopulationAgeQuantity per servingFrequency
Adolescents et adultesminimum: 12 years1 Crèmeminimum: 1 Tous les jours ; maximum: 2 Tous les jours
Enfants, adolescents et adultesminimum: 2 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps treat impetigo Helps treat mild to moderate acne vulgaris

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80128021

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line